Aeterna Zentaris Inc. (AEZS)
NASDAQ: AEZS · IEX Real-Time Price · USD
9.69
-0.24 (-2.42%)
At close: May 31, 2024, 4:00 PM
9.70
+0.01 (0.10%)
After-hours: May 31, 2024, 6:04 PM EDT
Aeterna Zentaris Revenue
In the year 2023, Aeterna Zentaris had annual revenue of $4.50M, a decrease of -20.25%. Revenue in the quarter ending December 31, 2023 was $121.00K, a -95.13% decrease year-over-year.
Revenue (ttm)
$4.50M
Revenue Growth
-20.25%
P/S Ratio
2.62
Revenue / Employee
$374,833
Employees
12
Market Cap
11.76M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.50M | -1.14M | -20.25% |
Dec 31, 2022 | 5.64M | 380.00K | 7.22% |
Dec 31, 2021 | 5.26M | 1.61M | 44.03% |
Dec 31, 2020 | 3.65M | 3.12M | 586.47% |
Dec 31, 2019 | 532.00K | -26.35M | -98.02% |
Dec 31, 2018 | 26.88M | 25.96M | 2,812.35% |
Dec 31, 2017 | 923.00K | 12.00K | 1.32% |
Dec 31, 2016 | 911.00K | 366.00K | 67.16% |
Dec 31, 2015 | 545.00K | 534.00K | 4,854.55% |
Dec 31, 2014 | 11.00K | -6.16M | -99.82% |
Dec 31, 2013 | 6.18M | 4.12M | 200.78% |
Dec 31, 2012 | 2.05M | -2.65M | -56.37% |
Dec 31, 2011 | 4.71M | -23.00M | -83.02% |
Dec 31, 2010 | 27.70M | -35.53M | -56.19% |
Dec 31, 2009 | 63.24M | 24.76M | 64.35% |
Dec 31, 2008 | 38.48M | -3.59M | -8.53% |
Dec 31, 2007 | 42.07M | 3.27M | 8.43% |
Dec 31, 2006 | 38.80M | -6.01M | -13.42% |
Dec 31, 2005 | 44.81M | 1.84M | 4.28% |
Dec 31, 2004 | 42.97M | -75.77M | -63.81% |
Dec 31, 2003 | 118.74M | 40.81M | 52.37% |
Dec 31, 2002 | 77.93M | 44.22M | 131.18% |
Dec 31, 2001 | 33.71M | 27.24M | 420.84% |
Dec 31, 2000 | 6.47M | 1.73M | 36.49% |
Dec 31, 1999 | 4.74M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareMax | 810.36M |
Cosmos Health | 49.59M |
Sunshine Biopharma | 26.74M |
DermTech | 15.66M |
Ontrak | 12.89M |
Avalo Therapeutics | 1.45M |
AEZS News
- 3 days ago - Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date - GlobeNewsWire
- 15 days ago - Aeterna Zentaris Announces Details Regarding Transaction with Ceapro - GlobeNewsWire
- 18 days ago - Aeterna Zentaris Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Aeterna Zentaris Announces Effective Date of Share Consolidation - GlobeNewsWire
- 2 months ago - Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 3 months ago - Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company - GlobeNewsWire
- 3 months ago - Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro - GlobeNewsWire